Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD

NCT03836482 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute on Chronic Systolic Congestive Heart Failure
Cardiorenal Syndrome

Interventions

DEVICE: Selective Cytopheretic Device

Sponsor

SeaStar Medical

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)
University of Michigan
Innovative BioTherapies (IBT)